Evidence map›Paper›PMID 27052231›Full record

ReviewWiener klinische Wochenschrift2016

[Diabetic kidney disease - Update 2016].

Harald Sourij, Roland Edlinger, Friedrich Prischl, Martin Auinger, Alexandra Kautzky-Willer, Marcus D Säemann, Rudolf Prager, Martin Clodi, Guntram Schernthaner, Gert Mayer and 2 more

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Wiener klinische Wochenschrift, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Harald SourijKlinische Abteilung für Endokrinologie und Diabetologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Österreich.
Roland Edlinger3. Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien, Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Österreich.
Friedrich PrischlIV. Interne Abteilung/Bereich Nephrologie, Klinikum Wels-Grieskirchen, Wels, Österreich.
Martin Auinger3. Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien, Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Österreich.
Alexandra Kautzky-WillerKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Marcus D SäemannKlinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Rudolf Prager3. Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien, Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Österreich.
Martin ClodiAbteilung für Innere Medizin, Krankenhaus Barmherzige Brüder Linz, Linz, Österreich.
Guntram Schernthaner1. Medizinische Abteilung, Krankenhaus Rudolfstiftung, Wien, Österreich.
Gert MayerNephrologie und Hypertensiologie, Universitätsklinik für Innere Medizin IV, Innsbruck, Österreich.
Rainer OberbauerKlinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Alexander R RosenkranzKlinische Abteilung für Nephrologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Österreich. alexander.rosenkranz@medunigraz.at.
Klinik Hietzing · ATMedical University of Vienna · ATMedical University of Graz · ATKlinikum Wels-Grieskirchen · ATKrankenanstalt Rudolfstiftung der Stadt Wien · ATKrankenhaus Barmherzige Brüder · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent epidemiological evaluations have shown that approximately 5% of all Austrians suffer from diabetes including renal involvement, i. e. 400.000 people in Austria are affected. The risk of start and progression of this disease can be ameliorated by lifestyle interventions as well as optimization of blood pressure and glucose levels. The present article represents the joint recommendations of the Austrian Diabetes Association and the Austrian Society for Nephrology for the prevention and treatment of diabetic kidney disease.

Indexed as

Practice Guidelines as TopicRisk Reduction BehaviorAustriaDiabetic NephropathiesDiet TherapyEvidence-Based MedicineExercise TherapyHumansTreatment OutcomeChronic kidney diseaseDiabetic kidney diseaseDiabetic nephropathy

Identifiers

PMID27052231
OpenAlexW2341974811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.